Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.88 EUR
Market Cap: 55.8m EUR

Operating Margin
Shedir Pharma Srl Unipersonale

14.5%
Current
14%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.5%
=
Operating Profit
8.9m
/
Revenue
61m

Operating Margin Across Competitors

No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.4m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.5%
=
Operating Profit
8.9m
/
Revenue
61m
What is the Operating Margin of Shedir Pharma Srl Unipersonale?

Based on Shedir Pharma Srl Unipersonale's most recent financial statements, the company has Operating Margin of 14.5%.

Back to Top